Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression

被引:98
作者
Lee, Jeong-Yeon [1 ]
Kong, Gu [2 ]
机构
[1] Hanyang Univ, IBBR, Seoul, South Korea
[2] Hanyang Univ, Dept Pathol, Coll Med, 222 Wangsimni Ro, Seoul 04763, South Korea
基金
新加坡国家研究基金会;
关键词
EMT; EMT transcription factor; Human cancer; Epigenetics; Chromatin; Histone modification; DNA methylation; GROWTH-FACTOR RECEPTOR; E-CADHERIN EXPRESSION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; REPRESSES E-CADHERIN; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; STEM-CELLS; HISTONE DEMETHYLASE; DNA METHYLATION; UP-REGULATION;
D O I
10.1007/s00018-016-2313-z
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The epithelial-mesenchymal transition (EMT) is a crucial developmental process by which epithelial cells undergo a mesenchymal phenotypic change. During EMT, epigenetic mechanisms including DNA methylation and histone modifications are involved in the regulation of EMT-related genes. The epigenetic gene silencing of the epithelial marker E-cadherin has been well characterized. In particular, three major transcriptional repressors of E-cadherin, Snail, ZEB, and Twist families, also known as EMT-inducing transcription factors (EMT-TFs), play a crucial role in this process by cooperating with multiple epigenetic modifiers. Furthermore, recent studies have identified the novel epigenetic modifiers that control the expression of EMT-TFs, and these modifiers have emerged as critical regulators of cancer development and as novel therapeutic targets for human cancer. In this review, the diverse functions of EMT-TFs in cancer progression, the cooperative mechanisms of EMT-TFs with epigenetic modifiers, and epigenetic regulatory roles for the expression of EMT-TFs will be discussed.
引用
收藏
页码:4643 / 4660
页数:18
相关论文
共 202 条
[81]   Selective targeting of cancer stem cells - A new concept in cancer therapeutics [J].
Korkaya, Hasan ;
Wicha, Max S. .
BIODRUGS, 2007, 21 (05) :299-310
[82]   The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2 [J].
Korpal, Manav ;
Lee, Esther S. ;
Hu, Guohong ;
Kang, Yibin .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (22) :14910-14914
[83]   Cancer Metastasis Is Accelerated through Immunosuppression during Snail-induced EMT of Cancer Cells [J].
Kudo-Saito, Chie ;
Shirako, Hiromi ;
Takeuchi, Tadashi ;
Kawakami, Yutaka .
CANCER CELL, 2009, 15 (03) :195-206
[84]   Myc-mediated transcriptional repression by recruitment of histone deacetylase [J].
Kurland, John F. ;
Tansey, Wilham P. .
CANCER RESEARCH, 2008, 68 (10) :3624-3629
[85]   Up-regulation of TWIST in prostate cancer and its implication as a therapeutic target [J].
Kwok, WK ;
Ling, MT ;
Lee, TW ;
Lau, TCM ;
Zhou, C ;
Zhang, XM ;
Chua, CW ;
Chan, KW ;
Chan, FL ;
Glackin, C ;
Wong, YC ;
Wang, XH .
CANCER RESEARCH, 2005, 65 (12) :5153-5162
[86]   TWIST1 promoter methylation is associated with prognosis in tonsillar squamous cell carcinoma [J].
Kwon, Mi Jung ;
Kwon, Ji Hyun ;
Nam, Eun Sook ;
Shin, Hyung Sik ;
Lee, Dong Jin ;
Kim, Jin Hwan ;
Rho, Young Soo ;
Sung, Chang Ohk ;
Lee, Won Jae ;
Cho, Seong Jin .
HUMAN PATHOLOGY, 2013, 44 (09) :1722-1729
[87]   DOT1L: a new therapeutic target for aggressive breast cancer [J].
Lee, Jeong-Yeon ;
Kong, Gu .
ONCOTARGET, 2015, 6 (31) :30451-30452
[88]   MEL-18, a tumor suppressor for aggressive breast cancer [J].
Lee, Jeong-Yeon ;
Kong, Gu .
ONCOTARGET, 2015, 6 (18) :15710-15711
[89]   Cytotoxicity Comparison of the Nanoparticles Deposited on Latex Rubber Bands between the Original and Stretched State [J].
Lee, Jung-Hwan ;
Lee, Eun-Jung ;
Kwon, Jae-Sung ;
Hwang, Chung-Ju ;
Kim, Kyoung-Nam .
JOURNAL OF NANOMATERIALS, 2014, 2014
[90]  
Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042